About Luitpold
Luitpold is a Healthcare company based in New York (United States) founded in 1910, and was acquired by Daiichi Sankyo in June 1990. Traditional pharma company engaged in development and marketing of variety of pharmaceutical products and medical devices. Luitpold has completed 2 acquisitions, including American Regent and Roxro Pharma. Its focus areas include Diversified Pharmaceuticals.
Company details
Luitpold Pharmaceuticals engages in the development and marketing of variety of pharmaceutical products and medical devices. Product categories include injectables, ophthalmics, critical care drugs, antidotes and medicinal dyes. The company also provides custom product development for the treatment of acute pain; veterinary products; bone regeneration materials and graft products for the dental industry. It also offers contract manufacturing services. The company was acquired by Sankyo in 1991 and now operates as wholly owned subsidiary of Daiichi Sankyo.
- Headquarters New York, United States
- Stage Acquired
- SectorsHealthcare
- Website luitpold.com
- Social LinkedIn
- Acquired by Daiichi Sankyo (Jun 1990)
- Investors
- Investments & AcquisitionsAmerican Regent
& 1 more
- Acquired byDaiichi Sankyo
(Jun 1990)
Investors in Luitpold
Luitpold has secured backing from 1 investor. Prominent investors backing the company include Daiichi Sankyo.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Pharmaceutical drugs are developed to address diverse medical needs. | 2005 | daiichisankyo.com | Tokyo, Japan |
Investor details for Luitpold
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Luitpold
11 people are tracked at Luitpold (11 in leadership).
| Name | Role | Group |
|---|---|---|
Paul Diolosa | President & CEO | Leadership |
Joseph Tedesco | VP, Information Technology | Leadership |
Joann Gioia | Chief Commercial Officer & VP | Leadership |
Derrick Bennett | VP of Manufacturing | Leadership |
Joseph Oestreicher | CPO & VP | Leadership |
Ravi Tayi | VP, Chief Medical Officer | Leadership |
Gopal Anyarambhatla | Chief Scientific Officer & VP | Leadership |
Joseph J. Boyle | CFO & VP | Leadership |
Gretchen Fritz | CLO & VP | Leadership |
Joel Steckler | VP, Commercial Operations, Animal Health | Leadership |
Nick Walp | VP of Quality Affairs | Leadership |
Complete people profiles for Luitpold
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Luitpold
Luitpold has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include American Regent and Roxro Pharma.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Acute pain drugs are developed from acquired failed candidates. | roxropharma.com | Menlo Park, United States | 1999 | Dec 2010 | •••• | |
Multiple pharmaceutical drugs are manufactured by PharmaForce. | pharmaforceinc.com | New Albany, United States | 1999 | Dec 2009 | •••• |
Complete acquisition details for Luitpold
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Luitpold
4 dated milestones of Luitpold across 100 years, from founding to its latest funding, stage changes and deals.
- Founded Luitpold is founded.
- Exit Acquired by Daiichi Sankyo.
- Acquisition Acquires American Regent.
- Acquisition Acquires Roxro Pharma.
Web traffic of Luitpold
The website of Luitpold (luitpold.com) receives about 1K visits a month.
- Monthly visits1K
▲ 464.4% vs previous month
Websites whose visitors overlap most with Luitpold. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
cebert.com | cebert.com | 100% | – | ||
| geminipharm.com | 90% | #2,449,109 | View details | ||
globalphar.com | globalphar.com | 89% | – | ||
parmed.com | parmed.com | 88% | #276,369 | – | |
| janssenpharmaceuticalsinc.com | 88% | View details | |||
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 10 similar websites and full traffic analytics for Luitpold
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 10 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Pharmaceuticals & Distribution
3 companies that operate in the same segment as Luitpold (Pharmaceuticals & Distribution) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | USD 33.23 B | 28,000 | ||
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | USD 5.33 B | 55,000 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Luitpold
Complete news archive for Luitpold
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Luitpold
Luitpold was founded in 1910.
Luitpold is headquartered in New York, United States. It is registered at New York, New York, United States.
Luitpold Pharmaceuticals engages in the development and marketing of variety of pharmaceutical products and medical devices. Product categories include injectables, ophthalmics, critical care drugs, antidotes and medicinal dyes. The company also provides custom product development for the treatment of acute pain; veterinary products; bone regeneration materials and graft products for the dental industry. It also offers contract manufacturing services. The company was acquired by Sankyo in 1991 and now operates as wholly owned subsidiary of Daiichi Sankyo.
Luitpold has made 2 acquisitions, including American Regent, and Roxro Pharma.
Luitpold has 1 investor. Key investors include Daiichi Sankyo.
Yes. Luitpold was acquired by Daiichi Sankyo in June 1990.